Skip to content

10-Panel Buprenorphine, Oxycodone & MDMA Rapid Drug Test Cup – 120 mL | AMP, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY & THC

In Stock

$6.99$2.85/each

Buy More, Save More
Quantity
1

Description

10 DRUG PANELS • BUP, OXY & MDMA • OPI/300 • 120 mL

10-Panel Buprenorphine, Oxycodone & MDMA Rapid Drug Test Cup

Comprehensive preliminary urine drug screening with dedicated buprenorphine, oxycodone and MDMA panels.

This self-contained 120 mL urine drug test cup screens for amphetamines, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone and marijuana.

Separate BUP, MTD, OPI and OXY panels provide expanded opioid-related screening, while the dedicated MDMA panel adds coverage for ecstasy-related compounds identified in the manufacturer’s package insert. Preliminary results are available in approximately five minutes.

Product Highlights

Ten-Drug Screening Screens for AMP, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY and THC.
Buprenorphine Screening Includes a dedicated BUP panel at the manufacturer-listed 10 ng/mL cutoff.
Oxycodone Screening Includes a separate OXY panel at the listed 100 ng/mL cutoff.
Dedicated MDMA Panel Screens for MDMA or ecstasy at the listed 500 ng/mL cutoff.
OPI/300 Screening Screens morphine and related opiates at the listed 300 ng/mL cutoff.
Expanded Opioid Coverage Includes separate BUP, MTD, OPI and OXY screening panels.
Results in Minutes Provides clear preliminary results in approximately five minutes.
One-Step Testing Collection and preliminary screening are completed using one integrated cup.
Large 120 mL Capacity Provides ample specimen capacity for convenient urine collection.
Leak-Resistant Click Lid Secure closure helps reduce leakage, spills and accidental opening.
Built-In Temperature Strip Supports prompt verification that specimen temperature is within the expected range.
Same-Day Shipping Eligible orders placed within the applicable processing window ship the same business day.
Ten Drug Panels with Buprenorphine, Oxycodone, MDMA and OPI/300 Screening A broad testing option for healthcare facilities, occupational health clinics, treatment programs, rehabilitation centers, collection sites, correctional settings and authorized workplace screening.

Drug Panels and Cutoff Levels

Review the ten drug categories and manufacturer-listed preliminary screening cutoff levels.

TEST STRIP TESTED DRUG ESTIMATED DETECTION TIME / CUTOFF
AMP   AMP   AMP   AMP   AMP
AMP   AMP   AMP   AMP   AMP
 Amphetamines 1–2 Days • 1,000 ng/mL
BUP   BUP   BUP   BUP   BUP
BUP   BUP   BUP   BUP   BUP
 Buprenorphine 2–6 Days • 10 ng/mL
BZO   BZO   BZO   BZO   BZO
BZO   BZO   BZO   BZO   BZO
 Benzodiazepines 1–2 Days • 300 ng/mL
COC   COC   COC   COC   COC
COC   COC   COC   COC   COC
 Cocaine 2–4 Days • 300 ng/mL
MDMA   MDMA   MDMA   MDMA
MDMA   MDMA   MDMA   MDMA
 MDMA / Ecstasy 2–4 Days • 500 ng/mL
MET   MET   MET   MET   MET
MET   MET   MET   MET   MET
 Methamphetamine 2–4 Days • 1,000 ng/mL
MTD   MTD   MTD   MTD   MTD
MTD   MTD   MTD   MTD   MTD
 Methadone 1–3 Days • 300 ng/mL
OPI   OPI   OPI   OPI   OPI
OPI   OPI   OPI   OPI   OPI
 Morphine / Opiates 2–3 Days • 300 ng/mL
OXY   OXY   OXY   OXY   OXY
OXY   OXY   OXY   OXY   OXY
 Oxycodone 1–3 Days • 100 ng/mL
THC   THC   THC   THC   THC
THC   THC   THC   THC   THC
 Marijuana 5+ Days • 50 ng/mL
Please Note: Detection windows vary according to dosage, frequency of use, metabolism, hydration, body composition, specimen concentration and other individual factors.  Refer to the manufacturer’s package insert for exact cutoff levels, cross-reactivity information and interpretation instructions.
Separate Buprenorphine, Opiate and Oxycodone Panels Buprenorphine and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Dedicated BUP, OPI and OXY strips provide targeted preliminary screening for each listed analyte.
Dedicated MDMA Screening The MDMA panel screens for ecstasy-related compounds identified in the manufacturer’s package insert at the listed 500 ng/mL cutoff.
Integrated Collection and Testing The 120 mL design combines urine collection, temperature verification and ten-panel preliminary screening in one self-contained device.

How to Use the 10-Panel Buprenorphine, Oxycodone & MDMA Rapid Drug Test Cup

Understanding the 10-Panel Buprenorphine, Oxycodone & MDMA Rapid Drug Test Cup Results


Product Dimensions and Specifications

10-Panel Buprenorphine, Oxycodone & MDMA Rapid Drug Test Cup
Drug panels AMP, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY and THC
Buprenorphine cutoff BUP/10
MDMA cutoff MDMA/500
Methadone cutoff MTD/300
Opiate cutoff OPI/300
Oxycodone cutoff OXY/100
Result time Approximately 5 minutes
Capacity 120 mL
Height 3.25 inches
Bottom width 2 inches
Lid width 2.63 inches
Approximate weight 0.18 lb
Manufacturer-listed shelf life Up to 24 months when stored according to package instructions

CLIA Waived and FDA 510(k) Cleared

According to the supplied manufacturer information, this exact 10-panel configuration is CLIA Waived and FDA 510(k) Cleared for the intended uses identified in its labeling. Verify the regulatory status shown on the exact product packaging before advertising or use.

What CLIA Waived Means Eligible point-of-care sites may use the test under a CLIA Certificate of Waiver when the manufacturer’s instructions and applicable requirements are followed.
What FDA 510(k) Cleared Means The device completed the applicable FDA premarket-clearance process for the intended uses identified in its authorized labeling.

Depending on its exact labeling and applicable requirements, this cup may be suitable for physician offices, healthcare facilities, occupational health clinics, treatment and rehabilitation programs, drug-testing collection sites, probation and correctional programs and qualifying workplace-screening programs.

Regulatory Notice: FDA clearance and CLIA-waived status are separate designations. State and local requirements may apply, and regulatory status can vary by exact cup configuration or individual assay.

Frequently Asked Questions

1. Which substances does this 10-panel cup screen for? It screens for amphetamines, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone and marijuana.
2. Why are buprenorphine and oxycodone included as separate panels? Buprenorphine and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Dedicated BUP and OXY strips provide targeted preliminary screening.
3. Does this cup include a dedicated MDMA panel? Yes. It includes a separate MDMA panel at the manufacturer-listed 500 ng/mL screening cutoff.
4. How quickly are results available? Preliminary results are available in approximately five minutes. Do not interpret results after eight minutes or outside the package insert’s stated reading window.
5. Does the temperature strip prove the specimen is authentic? No. It measures specimen temperature shortly after collection and helps identify samples outside the expected temperature range. It does not independently prove authenticity or detect dilution.
6. Is a presumptive positive result final? No. Presumptive positive results should be confirmed using an appropriate laboratory method before clinical, employment, treatment or legal decisions are made.
Ten Drug Panels. Buprenorphine, Oxycodone and MDMA Screening. One Convenient Cup. Simplify preliminary urine drug screening with a self-contained 120 mL cup designed for secure collection, rapid results and broad opioid-related coverage.
Order 10-Panel Drug Test Cups Today

Shipping & Delivery

  • All orders will be shipped the same day if placed before 3:00 PM EST.
  • Next-day shipments will not be delivered on weekends, and the time taken on air shipments should be counted as business days.

Why order from us

  • CLIA-waived screening supplies for qualified lab and point-of-care workflows.
  • Same-day shipping on orders placed before 3:00 PM EST.
  • Volume and bulk pricing available — contact us for recurring supply.